PHILADELPHIA, PA--(Marketwire - January 27, 2010) - Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that it is scheduled to present at the upcoming Deutsche Bank Securities Small- and Mid-Cap Conference. Presenting will be Bill Newbould, Eurand’s Vice President, Investor Relations.
Event: Deutsche Bank Securities Small- and Mid-Cap Conference Date: Tuesday, February 9, 2010 Time: 2:00 p.m. ET Location: The Ritz-Carlton, Naples, Fla.
An audio webcast of the presentation will be available by accessing the investor relations section of Eurand’s web site at www.eurand.com. A replay of the presentation will be available until March 9, 2010.
About Eurand
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation.
Eurand is a global company with facilities in the U.S. and Europe. For more information, visit Eurand’s website at www.eurand.com.
Contacts:
Bill Newbould
Vice President, Investor Relations
Eurand N.V.
+1 267-759-9335
Email Contact
Nick Laudico/Sara Pellegrino
The Ruth Group
+1 646-536-7030/7002
Email Contact
Email Contact
